Ginkgo Bioworks (NYSE: DNA) reported Q3 EPS of ($0.41), $0.12 worse than the analyst estimate of ($0.29). Revenue for the quarter came in at $66.4 million versus the consensus estimate of $60.35 million.

For earnings history and earnings-related data on Ginkgo Bioworks (DNA) click here.